These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20947080)

  • 41. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
    Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
    J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
    Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
    Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V
    J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria.
    Onyeneho NG; Orji BC; Okeibunor JC; Brieger WR
    Int J Gynaecol Obstet; 2013 Nov; 123(2):101-4. PubMed ID: 24041469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
    Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire.
    Vanga-Bosson HA; Coffie PA; Kanhon S; Sloan C; Kouakou F; Eholie SP; Kone M; Dabis F; Menan H; Ekouevi DK
    Malar J; 2011 Apr; 10():105. PubMed ID: 21529344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment.
    Cohee LM; Kalilani-Phiri L; Boudova S; Joshi S; Mukadam R; Seydel KB; Mawindo P; Thesing P; Kamiza S; Makwakwa K; Muehlenbachs A; Taylor TE; Laufer MK
    Malar J; 2014 Jul; 13():274. PubMed ID: 25023697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Compliance with intermittent preventive treatment during pregnancy among postpartum women in Ibadan, Nigeria.
    Oluwatosin OA; Aluko JO
    Afr J Med Med Sci; 2014 Mar; 43(1):67-74. PubMed ID: 25335380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
    Noguchi L; Grenier L; Kabue M; Ugwa E; Oyetunji J; Suhowatsky S; Onguti B; Orji B; Whiting-Collins L; Adetiloye O
    Malar J; 2020 Jan; 19(1):51. PubMed ID: 31996209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of malaria and intermittent preventive treatment during pregnancy on fetal anemia in Malawi.
    Rogawski ET; Chaluluka E; Molyneux ME; Feng G; Rogerson SJ; Meshnick SR
    Clin Infect Dis; 2012 Oct; 55(8):1096-102. PubMed ID: 22767651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of intermittent preventive treatment and insecticide treated nets on malaria parasitaemia in pregnancy among Igbo women in southeastern Nigeria.
    Ugboaja JO; Oguejiofor CO
    J Vector Borne Dis; 2017; 54(3):249-254. PubMed ID: 29097640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight.
    Wolfe EB; Parise ME; Haddix AC; Nahlen BL; Ayisi JG; Misore A; Steketee RW
    Am J Trop Med Hyg; 2001; 64(3-4):178-86. PubMed ID: 11442215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
    Tutu EO; Lawson B; Browne E
    Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi.
    Msyamboza KP; Savage EJ; Kazembe PN; Gies S; Kalanda G; D'Alessandro U; Brabin BJ
    Trop Med Int Health; 2009 Feb; 14(2):183-9. PubMed ID: 19207178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monthly sulphadoxine-pyrimethamine combination versus daily proguanil for malaria chemoprophylaxis in sickle cell disease: a randomized controlled study at the Jos University Teaching Hospital.
    Dawam JA; Madaki JKA; Gambazai AA; Okpe ES; Lar-ndam N; Onu A; Gyang M
    Niger J Med; 2016; 25(2):119-27. PubMed ID: 29944308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens.
    Tiono AB; Ouedraogo A; Bougouma EC; Diarra A; Konaté AT; Nébié I; Sirima SB
    Malar J; 2009 Oct; 8():224. PubMed ID: 19811649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized controlled trial of azithromycin and sulphadoxine-pyrimethamine as prophylaxis against malaria in pregnancy among human immunodeficiency virus-positive women.
    Akinyotu O; Bello F; Abdus-Salam R; Arowojolu A
    Trans R Soc Trop Med Hyg; 2019 Aug; 113(8):463-470. PubMed ID: 31140565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative study of mefloquine and sulphadoxine-pyrimethamine for malaria prevention among pregnant women with HIV in southwest Nigeria.
    Akinyotu O; Bello F; Abdus-Salam R; Arowojolu A
    Int J Gynaecol Obstet; 2018 Aug; 142(2):194-200. PubMed ID: 29719927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.